Nu Skin Enterprises (NYSE:NUS) Releases FY 2026 Earnings Guidance

Nu Skin Enterprises (NYSE:NUSGet Free Report) updated its FY 2026 earnings guidance on Thursday. The company provided earnings per share guidance of 0.700-1.100 for the period, compared to the consensus earnings per share estimate of 1.000. The company issued revenue guidance of $1.4 billion-$1.5 billion, compared to the consensus revenue estimate of $1.4 billion. Nu Skin Enterprises also updated its Q2 2026 guidance to 0.150-0.250 EPS.

Analysts Set New Price Targets

Several research firms have weighed in on NUS. Zacks Research upgraded Nu Skin Enterprises from a “strong sell” rating to a “hold” rating in a research report on Monday, April 13th. Weiss Ratings reiterated a “hold (c)” rating on shares of Nu Skin Enterprises in a report on Thursday, January 22nd. Finally, Wall Street Zen lowered Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research note on Saturday, February 14th. Two investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, Nu Skin Enterprises has an average rating of “Hold”.

Check Out Our Latest Stock Analysis on Nu Skin Enterprises

Nu Skin Enterprises Stock Down 4.0%

NUS stock traded down $0.30 during mid-day trading on Thursday, reaching $7.05. 539,230 shares of the company traded hands, compared to its average volume of 510,137. The company has a quick ratio of 1.40, a current ratio of 2.08 and a debt-to-equity ratio of 0.25. The firm’s 50 day moving average price is $7.51 and its 200 day moving average price is $9.24. The stock has a market cap of $339.08 million, a price-to-earnings ratio of 2.20 and a beta of 1.03. Nu Skin Enterprises has a fifty-two week low of $5.78 and a fifty-two week high of $14.62.

Nu Skin Enterprises (NYSE:NUSGet Free Report) last posted its quarterly earnings data on Thursday, May 7th. The company reported $0.14 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.15 by ($0.01). The firm had revenue of $320.61 million for the quarter, compared to analysts’ expectations of $329.70 million. Nu Skin Enterprises had a return on equity of 8.14% and a net margin of 10.79%.Nu Skin Enterprises has set its FY 2026 guidance at 0.700-1.100 EPS and its Q2 2026 guidance at 0.150-0.250 EPS. As a group, equities research analysts predict that Nu Skin Enterprises will post 1 EPS for the current fiscal year.

Nu Skin Enterprises Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 11th. Stockholders of record on Friday, February 27th were given a dividend of $0.06 per share. This represents a $0.24 dividend on an annualized basis and a dividend yield of 3.4%. The ex-dividend date was Friday, February 27th. Nu Skin Enterprises’s payout ratio is 7.50%.

Institutional Investors Weigh In On Nu Skin Enterprises

Several hedge funds have recently added to or reduced their stakes in NUS. Graham Capital Management L.P. increased its stake in shares of Nu Skin Enterprises by 7.7% during the fourth quarter. Graham Capital Management L.P. now owns 28,955 shares of the company’s stock valued at $279,000 after purchasing an additional 2,077 shares in the last quarter. Tower Research Capital LLC TRC increased its stake in Nu Skin Enterprises by 107.4% during the 2nd quarter. Tower Research Capital LLC TRC now owns 5,048 shares of the company’s stock valued at $40,000 after purchasing an additional 2,614 shares in the last quarter. Russell Investments Group Ltd. raised its holdings in Nu Skin Enterprises by 2.5% in the fourth quarter. Russell Investments Group Ltd. now owns 110,850 shares of the company’s stock worth $1,066,000 after buying an additional 2,738 shares during the last quarter. Rhumbline Advisers lifted its stake in shares of Nu Skin Enterprises by 3.7% in the second quarter. Rhumbline Advisers now owns 80,119 shares of the company’s stock worth $640,000 after buying an additional 2,856 shares in the last quarter. Finally, Amundi increased its position in shares of Nu Skin Enterprises by 18.8% during the first quarter. Amundi now owns 18,564 shares of the company’s stock valued at $127,000 after acquiring an additional 2,941 shares in the last quarter. Institutional investors own 82.84% of the company’s stock.

Nu Skin Enterprises Company Profile

(Get Free Report)

Nu Skin Enterprises, Inc is a Utah-based direct selling company that develops and distributes personal care products and dietary supplements. Operating through a network marketing model, Nu Skin offers a portfolio of wellness, anti-aging skin care, hair care and nutritional products designed to support healthy living and appearance. The company leverages independent distributors to market its offerings directly to consumers across multiple channels, including online platforms and localized events.

Founded in 1984 by Blake M.

Further Reading

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.